One brain measure, from lab to first human tests, could help new medicines prove themselves sooner

Brain medicines are among the hardest to get right: only a small share ever reach patients, partly because the way researchers measure a drug in animals is dropped for questionnaires once human testing begins, leaving teams unsure why a trial failed. Two British research firms, Cumulus Neuroscience and Transpharmation, will now line up the same brain-wave readings — recorded with a simple wireless headset — from animal studies through first human tests, so a medicine carries one clear, shared measure of whether it is working all the way through.

SDG 9 · Industry, innovation and infrastructure — Mechanism: tech innovation